Ablynx, Boehringer Ingelheim deal

Ablynx will receive a €5 million ($6.7 million) milestone payment from Boehringer under a 2007 deal to use Ablynx's Nanobody technology to discover, develop and commercialize up to 10 therapeutic prot...